Aluminum-adsorbed vaccine antigen (Alum-adsorbed antigen)

Aluminum-adsorbed vaccine antigens refer to a pharmaceutical formulation where specific immunogens are bound to aluminum-based salts, such as aluminum hydroxide or aluminum phosphate, to enhance the body's immune response (PMID: 22126710). This adsorption process is a cornerstone of vaccinology used to increase the stability and immunogenicity of antigens that might otherwise be rapidly cleared or fail to trigger a sufficient protective response (StatPearls: NBK544269). Biologically, the alum-antigen complex functions by creating a 'depot effect' at the injection site, allowing for the slow, sustained release of the antigen to the immune system. Furthermore, alum acts as an irritant that recruits and activates antigen-presenting cells, such as dendritic cells and macrophages, often through the activation of the NLRP3 inflammasome (PMID: 18509337). This interaction is essential for the prevention of infectious diseases, as it ensures the production of high-titer, long-lasting antibodies (CDC: Adjuvants and Vaccines). Despite its widespread use in vaccines like DTaP and Hepatitis B, alum-adsorbed antigens are primarily associated with Th2-type immune responses and are known to cause minor local safety concerns such as injection site soreness or nodules (PMID: 24842520).

Other names

Alum-precipitated antigenAluminum-adjuvanted vaccineAlum-adsorbed vaccineAluminum hydroxide-adsorbed antigenAluminum phosphate-adsorbed antigen

Aluminum-adsorbed antigens function through a 'depot effect,' where the aluminum salt traps the antigen at the injection site to allow for slow, sustained release. It also induces local cellular stress and damage-associated molecular patterns (DAMPs), which activate the NLRP3 inflammasome in macrophages and dendritic cells. This leads to the recruitment of immune cells, enhanced antigen uptake, and the promotion of a strong B-cell mediated (humoral) immune response.